October 26, 2006
Botox (botulinum toxin Type A) has been available in the United States for clinical use since 1989. At that time it was approved by the FDA for treatment of eye and facial muscle spasm disorders, blepharospasm and hemifacial spasm respectively. Then in 2000 the FDA approved Myobloc (botulinum toxin Type B) for treatment of cervical [...]
Read the full article →
September 29, 2006
Restless legs syndrome is a movement disorder that affects approximately 10% of the American population. Affected individuals have the uncontrollable urge to move their legs, particularly at night when sleeping. Symptoms can also occur with sitting for prolonged periods of time such as when driving, flying or watching a movie. If the condition worsens, the [...]
Read the full article →